“…For the DSS‐induced ulcerative colitis mice, ALA (30–60 mg/kg) also reduced the expression of IL‐6, COX‐2, TNF‐α, and M1‐positive macrophages (J. Kim et al, 2020; Reifen, Karlinsky, Stark, Berkovich, & Nyska, 2015). Also, ALA (10–200 mg/kg) improved LPS‐induced orchitis and cystitis in mice through the reduced expression of IL‐6, TNF‐α, COX‐2, PLA 2 , and iNOS by inhibiting the activation of the NF‐κB signaling pathway (Kapl, Ok, & Demir, 2017; Ok, Kaplan, Kizilgok, & Demir, 2020). ALA (360–1800 mg/kg) improved lung injury in LPS‐induced mice by reducing the infiltration of total cells and neutrophils, increasing the number of macrophages, and inhibiting the expression of TNF‐α, IL‐6, and IL‐1β (Zhu et al, 2020).…”